Cargando…
Systematic screening for cardiovascular risk at pharmacies
BACKGROUND: Early identification and treatment of cardiovascular risk factors (CVRFs) is essential to prevent excess morbidity, mortality and healthcare-related costs. We sought to investigate whether an active screening programme at pharmacies could identify a significant proportion of patients wit...
Autores principales: | Rohla, Miklos, Haberfeld, Heinz, Sinzinger, Helmut, Kritz, Harald, Tscharre, Maximilian, Freynhofer, Matthias K, Huber, Kurt, Weiss, Thomas W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5030615/ https://www.ncbi.nlm.nih.gov/pubmed/27738518 http://dx.doi.org/10.1136/openhrt-2016-000497 |
Ejemplares similares
-
Estimated 10-year cardiovascular mortality seriously underestimates overall cardiovascular risk
por: Jørstad, Harald T, et al.
Publicado: (2016) -
Addition of cystatin C predicts cardiovascular death better than creatinine in intensive care
por: Helmersson-Karlqvist, Johanna, et al.
Publicado: (2022) -
Association of social relationships with incident cardiovascular events and all-cause mortality
por: Gronewold, Janine, et al.
Publicado: (2020) -
Incident cardiovascular, renal, metabolic diseases and death in individuals identified for risk-guided atrial fibrillation screening: a nationwide cohort study
por: Wu, Jianhua, et al.
Publicado: (2023) -
Refined atrial fibrillation screening and cost-effectiveness in the German population
por: Schnabel, Renate B, et al.
Publicado: (2022)